复星医药

- 600196

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2020  2019  2018  2017  2016  2015  2014  2013  2012  2011 
复星医药(600196) 利润表
单位:万元
报表日期2020-09-302020-06-302020-03-312019-12-312019-09-30
一、营业总收入2,210,274.431,402,816.46588,050.722,858,515.202,122,761.87
营业收入2,210,274.431,402,816.46588,050.722,858,515.202,122,761.87
二、营业总成本2,056,270.541,302,505.20557,683.252,714,763.651,985,799.77
营业成本975,451.71621,587.17263,865.181,154,342.11853,665.75
营业税金及附加15,883.129,715.304,344.5125,983.6117,043.86
销售费用628,208.19393,106.70168,104.84984,675.84740,603.70
管理费用200,247.41128,807.1558,645.64259,078.15180,064.57
财务费用48,710.0628,846.3313,459.7086,543.8865,419.00
研发费用187,770.05120,442.5549,263.39204,140.06129,002.89
资产减值损失----------
公允价值变动收益342.442,339.35-22,591.95-35,315.90-13,028.03
投资收益167,290.76117,571.4364,889.40356,549.53153,747.51
其中:对联营企业和合营企业的投资收益108,583.5265,240.6420,098.07143,141.46111,850.30
汇兑收益----------
三、营业利润338,997.05232,203.1978,958.09449,355.51293,125.80
加:营业外收入1,255.88917.19354.537,738.236,083.71
减:营业外支出4,226.752,951.542,376.544,518.483,344.54
其中:非流动资产处置损失----------
四、利润总额336,026.19230,168.8576,936.07452,575.26295,864.97
减:所得税费用61,037.3139,208.1012,087.1378,223.1450,305.27
五、净利润274,988.88190,960.7464,848.94374,352.13245,559.70
归属于母公司所有者的净利润247,898.06171,471.0257,719.80332,161.76206,370.41
少数股东损益27,090.8219,489.737,129.1442,190.3739,189.28
六、每股收益
基本每股收益(元/股)0.97000.67000.23001.30000.8100
稀释每股收益(元/股)0.97000.67000.23001.30000.8100
七、其他综合收益-10,019.10-15,496.67-21,246.82-21,782.503,495.85
八、综合收益总额264,969.78175,464.0743,602.12352,569.63249,055.55
归属于母公司所有者的综合收益总额244,950.35166,054.7344,750.63312,840.38209,965.02
归属于少数股东的综合收益总额20,019.439,409.34-1,148.5139,729.2539,090.53
下载全部历史数据到excel中 返回页顶